Sangamo Therapeutics
SGMO
#8743
Rank
NZ$0.26 B
Marketcap
NZ$0.72
Share price
-1.75%
Change (1 day)
-60.40%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.73. In 2024 the company made an earnings per share (EPS) of NZ-$0.85.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-10.25%
2024NZ-$0.85
2022NZ-$2.080.81%
2021NZ-$2.0733.33%
2020NZ-$1.556.9%
2019NZ-$1.4522.54%
2018NZ-$1.181.43%
2017NZ-$1.17-31.37%
2016NZ-$1.7075.86%
2015NZ-$0.9748.72%
2014NZ-$0.65-17.02%
2013NZ-$0.789.3%
2012NZ-$0.72-39.44%
2011NZ-$1.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.57-2,631.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$23.89-3,356.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.32-2,597.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$6.15 738.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$10.87-1,581.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.18-1,760.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.15-120.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.53-718.18%๐Ÿ‡บ๐Ÿ‡ธ USA